Histatin 5-Spermidine Conjugates Have Enhanced Fungicidal Activity and Efficacy as a Topical Therapeutic for Oral Candidiasis
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Oropharyngeal candidiasis (OPC) is caused by the opportunistic fungi Candida albicans and is prevalent in immunocompromised patients, individuals with dry mouth, or patients with prolonged antibiotic therapies that reduce oral commensal bacteria. Human salivary histatins, including histatin 5 (Hst 5), are small cationic proteins that are the major source of fungicidal activity of saliva. However, Hsts are rapidly degraded in vivo , limiting their usefulness as therapeutic agents despite their lack of toxicity. We constructed a conjugate peptide using spermidine (Spd) linked to the active fragment of Hst 5 (Hst 5 4–15 ), based upon our findings that C. albicans spermidine transporters are required for Hst 5 uptake and fungicidal activity. We found that Hst 5 4–15 -Spd was significantly more effective in killing C. albicans and Candida glabrata than Hst 5 alone in both planktonic and biofilm growth and that Hst 5 4–15 -Spd retained high activity in both serum and saliva. Hst 5 4–15 -Spd was not bactericidal against streptococcal oral commensal bacteria and had no hemolytic activity. We tested the effectiveness of Hst 5 4–15 -Spd in vivo by topical application to tongue surfaces of immunocompromised mice with OPC. Mice treated with Hst 5 4–15 -Spd had significant clearance of candidal tongue lesions macroscopically, which was confirmed by a 3- to 5-log fold reduction of C. albicans colonies recovered from tongue tissues. Hst 5 4–15 -Spd conjugates are a new class of peptide-based drugs with high selectivity for fungi and potential as topical therapeutic agents for oral candidiasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice were treated with iron supplement at a dose that increases murine iron levels [19] and iron-treatment was further confirmed by total serum iron measurements in treated and control mice (Figure S1).”
From High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis (2022) · cites this paper as [19]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437
Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms
Joly, S., Maze, C., McCray, P. B., & Guthmiller, J. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1024-1029.2004 · Cited by 291
Anticandidal activity of major human salivary histatins
Xu, T., Levitz, S. M., Diamond, R. D., & Oppenheim, F. G. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2549-2554.1991 · Cited by 266
Host Cell Invasion and Virulence Mediated by Candida albicans Ssa1
Sun, J. N., Solis, N. V., Phan, Q. T., Bajwa, J. S., Kashleva, H., Thompson, A., Liu, Y., Dongari-Bagtzoglou, A., Edgerton, M., & Filler, S. G. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001181 · Cited by 220 · cited 1×
“Next, we tested the efficacy of Hst 54 –15-Spd as a topical application to an established infection in a murine model of oral candidiasis (34).”
MethodSelf-citationMouse model of oropharyngeal candidiasis
Solis, N. V., & Filler, S. G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.011 · Cited by 208
Park, H., Myers, C. L., Sheppard, D. C., Phan, Q. T., Sanchez, A. A., E. Edwards, J., & Filler, S. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00476.x · Cited by 207
Oral candidosis – Clinical challenges of a biofilm disease
Rautemaa, R., & Ramage, G. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.585606 · Cited by 188
Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5
Rothstein, D. M., Spacciapoli, P., Tran, L. T., Xu, T., Roberts, F. D., Dalla Serra, M., Buxton, D. K., Oppenheim, F. G., & Friden, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1367-1373.2001 · Cited by 188
Characteristics of cellular polyamine transport in prokaryotes and eukaryotes
Igarashi, K., & Kashiwagi, K. (2010) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2010.01.017 · Cited by 183
Synthetic histatin analogues with broad-spectrum antimicrobial activity
HELMERHORST, E. J., HOF, W. V. '., VEERMAN, E. C. I., SIMOONS-SMIT, I., & AMERONGEN, A. V. N. (1997) · Biochemical Journal · doi:10.1042/bj3260039 · Cited by 183
Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5
Li, X. S., Reddy, M. S., Baev, D., & Edgerton, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300680200 · Cited by 167
Self-citationWhole-saliva Proteolysis and Its Impact on Salivary Diagnostics
Thomadaki, K., Helmerhorst, E. J., Tian, N., Sun, X., Siqueira, W. L., Walt, D. R., & Oppenheim, F. G. (2011) · Journal of Dental Research · doi:10.1177/0022034511420721 · Cited by 159
Igarashi, K., & Kashiwagi, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj020 · Cited by 158
Hata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149 · cited 1×
“As an alternative to azole therapeutics, we report that topical treatment with Hst 54 –15-Spd was highly effective at doses well below those of systemic fluconazole (53), as tongues of treated animals had negligible white lesions within the area of topical application.”
BackgroundMeiller, T. F., Hube, B., Schild, L., Shirtliff, M. E., Scheper, M. A., Winkler, R., Ton, A., & Jabra-Rizk, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005039 · Cited by 140
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome
Conti, H. R., Baker, O., Freeman, A. F., Jang, W. S., Holland, S. M., Li, R. A., Edgerton, M., & Gaffen, S. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.5 · Cited by 133
Self-citationPleurotus and Agrocybe hemolysins, new proteins hypothetically involved in fungal fruiting
Berne, S., Križaj, I., Pohleven, F., Turk, T., Maček, P., & Sepčić, K. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00190-3 · Cited by 131
Ishijima, S. A., Hayama, K., Burton, J. P., Reid, G., Okada, M., Matsushita, Y., & Abe, S. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07055-11 · Cited by 127
Helmerhorst, E. J., Reijnders, I. M., van ’t Hof, W., Simoons-Smit, I., Veerman, E. C. I., & Amerongen, A. V. N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.702 · Cited by 127
Oudhoff, M. J., Kroeze, K. L., Nazmi, K., van den Keijbus, P. A. M., Hof, W. V. ‘., Fernandez‐Borja, M., Hordijk, P. L., Gibbs, S., Bolscher, J. G. M., & Veerman, E. C. I. (2009) · The FASEB Journal · doi:10.1096/fj.09-137588 · Cited by 118
Groenink, J., Walgreen-Weterings, E., Hof, W. V. ‘., Veerman, E. C. I., & Amerongen, A. V. N. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08730.x · Cited by 107
Effects of histatin 5 and derived peptides on Candida albicans
Ruissen, A. L. A., Groenink, J., Helmerhorst, E. J., Walgreen-Weterings, E., Hof, W. V. ‘., Veerman, E. C. I., & Amerongen, A. V. N. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560361 · Cited by 103
Sajjan, U. S., Tran, L. T., Sole, N., Rovaldi, C., Akiyama, A., Friden, P. M., Forstner, J. F., & Rothstein, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3437-3444.2001 · Cited by 98
Comparison of three different treatment methods for generalized denture stomatitis
Kulak, Y., Arıkan, A., & Delibalta, N. (1994) · Journal of Prosthetic Dentistry · doi:10.1016/0022-3913(94)90341-7 · Cited by 85
Jang, W. S., Bajwa, J. S., Sun, J. N., & Edgerton, M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07210.x · Cited by 83
Self-citationOral fluid proteolytic effects on histatin 5 structure and function
Helmerhorst, E. J., Alagl, A. S., Siqueira, W. L., & Oppenheim, F. G. (2006) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2006.06.005 · Cited by 82
Concentration and fate of histatins and acidic proline-rich proteins in the oral environment
Campese, M., Sun, X., Bosch, J. A., Oppenheim, F. G., & Helmerhorst, E. J. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2008.11.010 · Cited by 77
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections
Danesi, R., Senesi, S., Wout, J. W. V. ’., van Dissel, J. T., Lupetti, A., & Nibbering, P. H. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.2.309 · Cited by 73
den Hertog, A. L., Sang, H. W. W. F., Kraayenhof, R., Bolscher, J. G. M., Hof, W. V. ‘., Veerman, E. C. I., & Amerongen, A. V. N. (2004) · Biochemical Journal · doi:10.1042/bj20031785 · Cited by 68
Histatin 5 Uptake by Candida albicans Utilizes Polyamine Transporters Dur3 and Dur31 Proteins
Kumar, R., Chadha, S., Saraswat, D., Bajwa, J. S., Li, R. A., Conti, H. R., & Edgerton, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311175 · Cited by 68
Self-citationLi, R., Kumar, R., Tati, S., Puri, S., & Edgerton, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02295-12 · Cited by 60
Self-citationSun, X., Salih, E., Oppenheim, F. G., & Helmerhorst, E. J. (2009) · The FASEB Journal · doi:10.1096/fj.09-131045 · Cited by 59
Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans
Tsai, H., & Bobek, L. A. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00076-7 · Cited by 58
Wei, G., & Bobek, L. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2336-2342.2005 · Cited by 56
Chadwick, J., Jones, M., Chadwick, A. E., Stocks, P. A., Ward, S. A., Park, B. K., & O’Neill, P. M. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.02.035 · Cited by 55
Welling, M. M., Brouwer, C. P. J. M., van ′t Hof, W., Veerman, E. C. I., & Amerongen, A. V. N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-07 · Cited by 48
Peters, B. M., Zhu, J., Fidel, P. L., Scheper, M. A., Hackett, W., Shaye, S. E., & Jabra‐Rizk, M. A. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00632.x · Cited by 38
Groot, F., Sanders, R. W., ter Brake, O., Nazmi, K., Veerman, E. C. I., Bolscher, J. G. M., & Berkhout, B. (2006) · Journal of Virology · doi:10.1128/jvi.00796-06 · Cited by 38
Anti-lipopolysaccharide activity of histatins, peptides from human saliva
Sugiyama, K. (1993) · Cellular and Molecular Life Sciences · doi:10.1007/bf01929920 · Cited by 36
Kanaguchi, N., Narisawa, N., Ito, T., Kinoshita, Y., Kusumoto, Y., Shinozuka, O., & Senpuku, H. (2012) · BMC Oral Health · doi:10.1186/1472-6831-12-36 · Cited by 34
Treatment strategies for oropharyngeal candidiasis
Laudenbach, J. M., & Epstein, J. B. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902952854 · Cited by 34
Giacometti, A., Cirioni, O., Kamysz, W., D’Amato, G., Silvestri, C., Prete, M. S. D., Licci, A., Riva, A., Łukasiak, J., & Scalise, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1249-1252.2005 · Cited by 32
Tati, S., Jang, W. S., Li, R. Q., Kumar, R., Puri, S., & Edgerton, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061480 · Cited by 28
Self-citationStructure-Based Design of Potent Histatin Analogues
Brewer, D., & Lajoie, G. (2002) · Biochemistry · doi:10.1021/bi015926d · Cited by 28
Groenink, J., Ruissen, A. L. A., Lowies, D., Hof, W. V. ‘., Veerman, E. C. I., & Amerongen, A. V. N. (2003) · Journal of Dental Research · doi:10.1177/154405910308200918 · Cited by 14
In vitrosusceptibility of theStreptococcus millerigroup to antimicrobial peptides
Bartie, K. L., DeVine, D., Wilson, M. J., & Lewis, M. A. O. (2008) · International Endodontic Journal · doi:10.1111/j.1365-2591.2008.01404.x · Cited by 13
Higashi, K., Sakamaki, Y., Herai, E., Demizu, R., Uemura, T., Saroj, S. D., Zenda, R., Terui, Y., Nishimura, K., Toida, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186536 · Cited by 11
Polyamine Transport as a Target for Treatment ofPneumocystisPneumonia
Liao, C.-P., Phanstiel, O., Lasbury, M. E., Zhang, C., Shao, S., Durant, P. J., Cheng, B.-H., & Lee, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00662-09 · Cited by 10
Zamperini, C. A., Schiavinato, P. C. D. S., Pavarina, A. C., Giampaolo, E. T., Vergani, C. E., & Machado, A. L. (2012) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12006 · Cited by 5
Cited by
How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5
Puri, S., & Edgerton, M. (2014) · Eukaryotic Cell · doi:10.1128/ec.00095-14 · Cited by 186
Self-citationDesign and Application of Antimicrobial Peptide Conjugates
Reinhardt, A., & Neundorf, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050701 · Cited by 160
Malik, E., Dennison, S. R., Harris, F., & Phoenix, D. A. (2016) · Pharmaceuticals · doi:10.3390/ph9040067 · Cited by 179
Tati, S., Davidow, P., McCall, A., Hwang-Wong, E., Rojas, I. G., Cormack, B., & Edgerton, M. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005522 · Cited by 141
Self-citationHistatin peptides: Pharmacological functions and their applications in dentistry
Khurshid, Z., Najeeb, S., Mali, M., Moin, S. F., Raza, S. Q., Zohaib, S., Sefat, F., & Zafar, M. S. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2016.04.027 · Cited by 132
Metadata
- Authors
- Tati, S., Li, R., Puri, S., Kumar, R., Davidow, P., & Edgerton, M.
- Affiliations
- University at Buffalo, State University of New York (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 58
- Issue
- 2
- Pages
- 756-766
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3910849
- OpenAlex
- W2077614764
- Cited by
- 36
- References
- 56
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 8 · 2015: 3 · 2014: 3
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Dental and Craniofacial Research (R01DE010641)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Keywords
- histatin 5, oropharyngeal candidiasis, Candida albicans, Candida glabrata, antifungal peptides, biofilm, topical antifungal therapy, immunodeficient mice, oral candidiasis, peptide drug design
- MeSH terms
- Animals, Antifungal Agents, Biological Transport, Candida albicans, Candidiasis, Oral, Female, Humans, Mouth Mucosa, Oligopeptides, Plankton, Spermidine, Immunocompromised Host, Biofilms, Candida glabrata, Mice, Histatins, Administration, Mucosal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.